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        Introduction 
  During retinal development, multipotent progenitor cells give 
rise to the neurons and M  ü  ller glia of the mature retina. In mam-
mals, retinal neurogenesis ends by the early postnatal period 
(  Reh and Fischer, 2006  ). Although a small number of quiescent 
retinal stem/progenitor cells persist at the margin of the mature 
retina near the junction of the ciliary epithelium (CE;   Ahmad 
et al., 2000  ;   Tropepe et al., 2000  ), progenitor cell proliferation 
and neuronal differentiation are no longer evident. As retinal stem 
cell therapy has promising therapeutic potential for eye patholo-
gies (  Young, 2005  ;   MacLaren et al., 2006  ), it is necessary to 
identify the factors that regulate retinal progenitor cell (RPC) 
proliferative capacity. 
  The expression of Toll-like receptor 4 (TLR4) has been 
recently documented in the ciliary body of the mammalian eye 
(  Brito et al., 2004  ). TLR4 is primarily identifi  ed as an innate 
immune receptor (  Takeda and Akira, 2005  ); therefore, its func-
tion in the eye has been commonly attributed to the immune 
response (  Kumar et al., 2004  ;   Chang et al., 2006  ). However, be-
cause TLRs recognize patterns rather than specifi  c molecules, 
along with their ability to recognize physiological compounds 
( Ohashi et al., 2000 ;  Okamura et al., 2001 ;  Johnson et al., 2003 ), 
they are endowed with the innate ability to mediate a rapid re-
sponse to a wide range of signals in the microenvironment and not 
merely to pathogens. 
  Nonimmune functions of the TLR family have been re-
ported in   Drosophila melanogaster   in establishing the dorsal  –
  ventral axis polarity, in synaptogenesis, and in axon pathfi  nding 
during embryogenesis ( Anderson et al., 1985 ;  Halfon et al., 1995 ; 
  Rose et al., 1997  ). Such nonimmune functions of this receptor 
family have only recently emerged in mammals. We have recently 
shown that in the adult mammalian central nervous system 
(CNS), TLRs, including TLR4, regulate adult hippocampal neuro-
genesis (  Rolls et al., 2007  ). In mammalian brain development, 
other members of the TLR family, TLR3 and TLR8, were identi-
fi  ed as negative regulators of axonal/neurite outgrowth (  Ma et al., 
2006  ;   Cameron et al., 2007  ). Conversely, TLR4 was found to be 
absent in neurons during the developmental stages of CNS for-
mation (  Lehnardt et al., 2003  ); however, with age, its expression 
levels increase (  Wadachi and Hargreaves, 2006  ). 
  R
etinal neurogenesis ceases by the early postnatal 
period, although retinal progenitor cells (RPCs) per-
sist throughout life. In this study, we show that in the 
mammalian eye, the function of Toll-like receptor 4 (TLR4) 
extends beyond regulation of the innate immune response; 
it restricts RPC proliferation. In TLR4-deﬁ  cient mice, en-
hanced proliferation of cells reminiscent of RPCs is evident 
during the early postnatal period. In vitro experiments 
demonstrate that TLR4 acts as an intrinsic regulator of RPC 
fate decision. Increased TLR4 expression in the eye cor-
relates with the postnatal cessation of cell proliferation. 
However, deﬁ  cient TLR4 expression is not sufﬁ  cient to ex-
tend the proliferative period but rather contributes to re-
sumption of proliferation in combination with growth 
factors. Proliferation in vivo is inhibited by both MyD88-
dependent and -independent pathways, similar to the 
mechanisms activated by TLR4 in immune cells. Thus, our 
study attributes a novel role to TLR4 as a negative regula-
tor of RPC proliferation.
  Toll-like receptor 4 restricts retinal progenitor 
cell proliferation 
    Ravid     Shechter  ,   
1       Ayal     Ronen  ,   
1       Asya     Rolls  ,   
1       Anat     London  ,   
1       Sharon     Bakalash  ,   
2       Michael J.     Young  ,   
2     
and   Michal     Schwartz     
1     
   
1  Department of Neurobiology, Weizmann Institute of Science, 76100 Rehovot, Israel 
   
2  Department of Ophthalmology, Schepens Eye Research Institute, Harvard Medical School, Boston, MA 02114       
© 2008 Shechter et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the ﬁ  rst six months after the publica-
tion date (see http://www.jcb.org/misc/terms.shtml). After six months it is available under a 
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, 
as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).JCB • VOLUME 183 • NUMBER 3 • 2008  394
RPCs, raised the possibility that TLR4 may play a role in the 
mammalian retina in RPC fate determination. 
  In this study, we identifi  ed TLR4 as a negative regula-
tor of RPC proliferation. During the early postnatal period, 
  Collectively, the functions that have been recently attrib-
uted to TLRs in the mammalian CNS, the changes in TLR ex-
pression pattern with development, and the evidence of TLR4 
expression in the retinal ciliary body, a location known to harbor 
  Figure 1.       Deﬁ   ciency in TLR4 results in in-
creased proliferation of cells reminiscent of 
RPCs in the early postnatal retina.   (A) Semi-
quantitative PCR of PN6 whole eyes for TLR1 –  9. 
(B) Staining for TLR4 of a PN6 eye. (C and D) 
Pictures of the CE labeled with TLR4 and the 
endothelial marker CD34 (C) or the epithelial 
markers cytokeratin 18 (CK18) and AE1/AE3 (D, 
inset). (E and F) Staining for nestin and TLR4 
coexpression (E) or BrdU, Chx10, and TLR4 
(F) in the CE. (G) Labeling of BrdU and TLR4 in 
the CE; right panel is a z axis projection of the 
boxed area. (H) Pictures of BrdU or Ki67 in the 
CE and the peripheral retina of WT and TLR4D 
PN6 mice. (I and J) Quantiﬁ  cation of prolifer-
ating cells in the CE (I) and in the peripheral 
retina (J). (K) Quantiﬁ  cation of BrdU 
+  /nestin 
+  , 
BrdU 
+  /Pax6 
+  , and BrdU 
+  /Chx10 
+   cells. (L  –  N) 
Representative pictures of nestin/BrdU (L), 
Pax6/BrdU (M), and Chx10/BrdU (N) stain-
ing. Arrows indicate double-labeled cells. As-
terisks denote signiﬁ  cant differences between 
the indicated groups: *, P   <   0.05; **, P   <   
0.01; ***, P   <   0.001; Student  ’  s   t   test,   n   = 4. 
Error bars represent SEM. Bars: (B) 100   μ  m; 
(C  –  G) 20   μ  m; (individual cell in G) 10   μ  m; 
(H and L  –  N) 50   μ  m.     395 TOLL-LIKE RECEPTOR 4 IN RETINAL NEUROGENESIS   • Shechter et al. 
  We next examined whether cell proliferation in the mam-
malian eye is affected by the absence of TLR4. To that end, we 
compared proliferation between wild-type (WT) and TLR4D 
PN6 mice assessed by BrdU incorporation and staining for the 
proliferation marker Ki67, a nuclear protein expressed in all phases 
of the cell cycle except the resting phase. The number of prolif-
erating cells was higher in the TLR4D mice relative to the matched 
WT controls both in the CE and the peripheral retina (  Fig. 1, 
H – J ).  Next,  double  immunohistochemical  analysis  confi  rmed 
that the observed increase in proliferation occurred in cells 
  expressing the neural progenitor marker nestin and the retinal 
progenitor markers Pax6 and Chx10 (  Fig. 1, K  –  N  ). 
  Quantitative analysis 7 d after injection revealed an in-
creased number of BrdU 
+   cells expressing the neuronal marker 
   III-tubulin (  IIIT) in the TLR4D mice (16,590  ±  1,872 vs. 8,480  ±  
2,687, TLR4D vs. WT, respectively; Student  ’  s   t   test, *, P = 0.05). 
This increase was not solely a result of enhanced proliferation but 
also an outcome of increased differentiation into neuronal cells 
(  Fig. 2, A  –  C  ). Because rod photoreceptors and bipolar cells are 
the major retinal neuronal cells formed during late histogenesis, 
we also quantifi  ed the percentage (out of total BrdU 
+   cells) of the 
bipolar-specifi  c marker PKC-     and the photoreceptor-specifi  c 
marker recoverin. Increased differentiation into the tested retinal 
neuronal cell types was evident in TLR4D mice (  Fig. 2, A and B  ). 
Notably, these differences did not result from differential sur-
vival, as no effect on apoptosis (measured by cleaved caspase 3) 
was observed (  Fig. 2 B  ). Collectively, these results suggest that in 
the PN6 retina, defi  ciency in TLR4 leads to both enhanced prolif-
eration and neuronal differentiation of cells expressing markers 
characteristic of retinal progenitors. 
  TLR4 activation has a direct effect on RPC 
fate decision 
  We next sought to determine whether the observed effects de-
scribed in vivo could be attributed to a direct infl  uence of TLR4 
TLR4-defi  cient (TLR4D) mice exhibited enhanced proliferation 
of cells expressing molecular markers commonly attributed to 
RPCs. In vitro experiments demonstrated that TLR4 directly 
modulates RPC fate decision. The increase in TLR4 levels, which 
coincided with the cessation of proliferation in the ciliary body, 
was found to be one of the factors that contributed to the de-
crease in proliferation. Thus, we suggest that although TLR4 is 
not the primary factor that regulates RPC proliferative capacity 
throughout life, it does determine the sensitivity of these cells to 
the microenvironment. 
  Results and discussion 
  TLR4 deﬁ  ciency results in increased 
proliferation and neuronal differentiation 
in the postnatal mammalian retina 
  To assess the effect of TLR4 on RPC proliferation, we analyzed 
retinas from postnatal day 6 (PN6) mice, which is the latest time 
point at which intense proliferation in the mammalian retina has 
been described (  Blanks and Bok, 1977  ;   Young, 1985  ). We found 
by PCR that TLR4 is the dominant TLR family member expressed 
(  Fig. 1 A  ). In agreement with   Brito et al., (2004)  , immunohisto-
chemical analysis revealed that TLR4 is expressed in the retina 
and the CE (  Fig. 1 B  ), a location that has been shown to harbor a 
retinal progenitor population (  Ahmad et al., 2000  ;   Tropepe et al., 
2000  ). We next identifi  ed the specifi  c population of cells that ex-
presses TLR4 in the ciliary body. TLR4-positive cells hardly ex-
pressed markers characteristic of endothelial (CD34;   Fig. 1 C  ) or 
epithelial (cytokeratin 18 and AE1/AE3;   Fig. 1 D  ) cells but ex-
pressed molecular markers characteristic of RPCs such as nestin, 
a neural progenitor marker (  Fig. 1 E  ), and Chx10, a retinal pro-
genitor marker ( Fig. 1 F ). To further strengthen our hypothesis that 
the TLR4-positive cells are proliferating RPCs, we injected the 
6-d-old mice with the cell proliferation marker BrdU. BrdU-
  positive cells that coexpressed TLR4 were detected (  Fig. 1 G  ). 
  Figure 2.       Deﬁ  ciency in TLR4 in the early postnatal retina results 
in increased neuronal differentiation.   (A) Staining for BrdU and 
the neuronal cell-speciﬁ  c markers     IIIT, PKC-    , and recoverin or 
the apoptotic marker cleaved caspase 3. (B) Percentage of BrdU 
+   
cells coexpressing each of the tested markers out of the total BrdU 
+   
cells (Student  ’  s   t   test,   n   = 4 per group; *, P   <   0.05). Error bars rep-
resent SEM. (C) Staining for BrdU and the neuronal marker DCX 
in retinas of WT and TLR4D mice. Arrows indicate double-labeled 
cells. Bars: (A and C) 20   μ  m; (individual cells) 10   μ  m.     JCB • VOLUME 183 • NUMBER 3 • 2008  396
signaling, which relies on cytoplasmic adaptor molecules that 
can associate with the intracellular region of the TLR molecule, 
exerts its effect via two main signaling pathways, MyD88 (my-
eloid differentiation primary response protein 88)-dependent 
and -independent cascades. The former involves the activation 
of the intracellular adaptor MyD88, and the latter entails the 
participation of another adaptor, TICAM1 (TIR domain  –
    containing adaptor protein inducing INF-   ;   Akira  and  Takeda, 
2004  ;   Krishnan et al., 2007  ). 
  Previous studies indicated that in developing neurons, 
TLR activation does not activate NF    B (  Ma et al., 2006  ;   Cameron 
et al., 2007  ), demonstrating that a different signaling pathway is 
induced in these cells. In contrast, TLR4 activation in adult neu-
ral progenitor cells results in the activation of both MyD88-
  dependent and -independent pathways (  Rolls et al., 2007  ), 
similar to the pathways activated in the immune system. As the 
proliferation of RPCs can be considered a recapitulation of 
both neurogenesis and developmental processes, we wished to 
identify the signaling pathways used in this process. Therefore, 
we tested whether MyD88 and TICAM1 participate in the regu-
lation of cell proliferation in the eye. We found increased num-
bers of BrdU 
+   cells in the peripheral retina and the CE of both 
MyD88- and TICAM1-defi  cient mice relative to WT PN6 mice 
( Fig.  4,  A – C ).  We  further  confi  rmed that the proliferating cells 
expressed markers characteristic of RPCs, including nestin, 
Pax6, and Chx10 (  Fig. 4 D  ). Our results therefore suggest that 
cell proliferation in the early postnatal eye is inhibited by both 
MyD88-dependent and -independent pathways, similar to the 
mechanism activated by TLRs in immune cells. 
on RPCs. To address this issue, we fi  rst tested whether TLRs are 
expressed by RPCs in vitro. Undifferentiated RPCs express 
mRNA that encodes for members of the TLR family (TLR1  –  9), 
with pronounced expression of TLR4 (  Fig. 3 A  ). Using TLR4-
specifi  c antibodies, we verifi  ed that RPCs indeed express this 
receptor ( Fig. 3, B – D ). To examine whether the TLR4 expressed 
on the RPCs affects their proliferation, we used an activator of 
TLR4, ultrapurified lipopolysaccharide (upLPS;   Akira and 
Takeda, 2004  ). Reduction of sphere diameter and proliferation 
were observed in the presence of upLPS ( Fig. 3, E – G ).  Treatment 
with upLPS did not affect RPC viability (  Fig. 3 H  ). Further-
more, suppression of TLR4 expression using TLR4-targeted 
siRNA increased the sphere diameter by 19.5   ±   3.9% (  n   =  46 – 56; 
Student ’ s  t   test, *, P = 0.0004;   Fig. 3 I  ). Next, we examined the 
ability of TLR4 expressed on RPCs to direct their differentia-
tion into neurons. Activation of TLR4 on RPCs using upLPS 
inhibited neuronal differentiation assessed by   IIIT and double-
cortin (DCX;   Fig. 3, J and K  ) and had no effect on differentia-
tion to the other lineages. Collectively, these results suggest that 
TLR4 is an intrinsic regulator, restricting both the proliferation 
and neuronal differentiation of RPCs. 
  Deﬁ  ciency in the common adaptors of TLR 
signaling, MyD88 or TICAM1, results in 
increased proliferation in the postnatal 
mammalian retina 
  In the classical immune response, TLR signaling leads to the 
activation of the transcription factor NF    B, which acts as a 
master switch, regulating the transcription of many genes. TLR 
  Figure 3.       Activation of TLR4 on RPCs directly 
restricts their proliferation and neuronal dif-
ferentiation in vitro.   (A) Semiquantitative PCR 
analysis of RPCs for TLR expression. (B  –  D) RPC 
spheres stained for TLR4 and the neural pro-
genitor marker nestin (B) or the retinal progeni-
tor markers Pax6 (C) and Chx10 (D). Insets 
depict single cells at higher magniﬁ  cation. 
(E)  Pictures of RPC spheres with or without 
upLPS treatment. (F) Quantiﬁ  cation of sphere 
diameter in the presence of upLPS (factorial 
ANOVA: F = 177.5; *, P = 0.0001). (G and H) 
Effect of upLPS on RPC proliferation (G; fac-
torial ANOVA: F = 7.434; *, P = 0.0008) 
and survival (H; factorial ANOVA: F = 46.27; 
*, P = 0.0001) determined by XTT assay. 
(I) Pictures of RPCs treated with siRNA for TLR4. 
(J) Differentiated RPCs with or without upLPS 
treatment stained for     IIIT. (K) Percentages of 
RPC differentiation to     IIIT 
+   or DCX 
+   cells (fac-
torial ANOVA:     IIIT, F = 16.92; *, P = 0.0001; 
and DCX, F = 14.73; *, P = 0.0003). Facto-
rial ANOVA followed by Fisher  ’  s exact test; *, 
P = 0.05. Error bars represent SEM. Bars: 
(B  –  D) 20   μ  m; (individual cells) 10   μ  m; (E) 100 
  μ  m; (I and J) 50   μ  m.     397 TOLL-LIKE RECEPTOR 4 IN RETINAL NEUROGENESIS   • Shechter et al. 
( Fig.  5,  A – C ).  Thus,  our  fi  ndings suggest that even though it 
cannot be considered the primary limiting factor of RPC prolif-
eration in adulthood, enhanced TLR4 expression in the eye con-
tributes to the restriction of RPC proliferation. 
  In this study, we identifi  ed TLR4 as a novel player in the 
regulation of RPC proliferation in the mammalian eye. We found 
that TLR4 inhibits proliferation of retinal cells expressing pro-
genitor markers in the early postnatal period and contributes to 
their lack of proliferation in the subsequent time period. In vitro 
experiments confi  rmed that TLR4 is expressed on the RPCs and 
directly affects their cell fate decision. Notably, TLR4 does not 
belong to any of the previously known classes of cell  –  cell sig-
naling pathways used to determine the fate of RPCs (  Yang, 2004  ). 
Interestingly, the major classes of known cell  –  cell signaling path-
ways share a common property with the TLR orthologue, as they 
all participate in dorsal  –  ventral patterning in   Drosophila   ( Biemar 
et al., 2006  ). Moreover, because similar effects of TLR4 on neural 
  Deﬁ  ciency in TLR4 promotes proliferation 
obtained by growth factor (GF) 
administration 
 Although adult retinal stem/progenitor cells exhibit self-renewal 
capacity in culture (  Tropepe et al., 2000  ), their proliferation in 
the mature eye of rodents is not evident after the second postna-
tal week (  Blanks and Bok, 1977  ;   Young, 1985  ). The inhibitory 
role of TLR4 on cell proliferation at PN6 identifi  ed in this study 
along with the known progressive time-dependent decrease of 
proliferating progenitors prompted us to test whether TLR4 de-
termines the time period at which proliferation occurs. Therefore, 
we explored whether TLR4 levels become elevated as animals 
enter adulthood and whether such an increase in TLR4 expres-
sion might explain the limited proliferation in the adult eye. 
We found elevated TLR4 levels in the CE from day 12 onwards 
relative to day 6 (  Fig. 5, A  –  C  ). 
  The observed correlation between the elevated levels of 
TLR4 expression and the cessation of cell proliferation prompted 
us to test whether defi  ciency in the TLR4 receptor might enable 
extension of the time period in which proliferation is observed. 
As long as proliferation was detectable in the peripheral retina, 
defi  ciency in TLR4 resulted in increased proliferation relative 
to WT (  Fig. 5, D and E  ). Because the absence of TLR4 had no 
effect on proliferation at later time points (  Fig. 5 E  ), we suggest 
that TLR4 signaling represents a secondary mechanism restrict-
ing proliferation in the adult eye. 
  The absence of proliferating RPCs in the adult eye can be 
either attributed to the lack of proliferation-promoting factors or 
to the presence of inhibitory molecules. The former was recently 
demonstrated, as GF administration results in in vivo prolifera-
tion of cells expressing markers characteristic of RPCs (  Fischer 
and Reh, 2003  ;   Zhao et al., 2005  ). Therefore, we tested whether 
TLR4 participates in restricting proliferation when GFs are pro-
vided (  Fischer and Reh, 2003  ;   Zhao et al., 2005  ). We intra-
vitreally injected FGF-2 and insulin as previously described 
( Zhao  et  al., 2005  ) to WT and TLR4D mice at PN15 (  Fig. 5 F  ). 
Incorporation of BrdU, which was injected together with the 
GF,   revealed, as expected, an extension of the proliferation pe-
riod. As in the early postnatal stage, providing the eye with GF 
resulted in signifi  cantly higher proliferation in the TLR4D mice 
compared with the WT animals (  Fig. 5, G  –  I  ), indicating that 
TLR4 had a negative impact on proliferation when conditions 
permissive for RPC proliferation were restored. To confi  rm 
these results and to demonstrate the effect of GFs on cell prolif-
eration, we analyzed retinas for the expression of Ki67. A higher 
number of proliferating cells was seen in the GF-treated retinas 
relative to controls in both strains (  Fig. 5 J  ); however, the effect 
was far more pronounced in the TLR4D mice (fourfold increase) 
than in their matched controls (2.5-fold increase;   Fig. 5 J  ). 
We further confi  rmed that the observed increased proliferation 
involved cells expressing markers distinguishing RPCs, such as 
Pax6 and Chx10 (  Fig. 5, K and L  ). These results suggest that 
under permissive conditions, TLR4 down-regulates prolifera-
tion. Importantly, defi  ciency in TLR4 had a more pronounced 
effect on proliferation in the PN15 eyes supplied with GF rela-
tive to PN6 eyes (  Fig. 5 M  ). This pronounced effect is supported 
by the enhanced expression of TLR4 at PN15 relative to PN6 
  Figure 4.       Deﬁ  ciency in the intracellular adaptors MyD88 or TICAM1 in-
creases proliferation in the retinas of PN6 mice.   (A) Representative pic-
tures of MyD88-deﬁ   cient (MyD88D), TICAM1-deﬁ   cient (TICAM1D), and 
WT PN6 retinas stained for BrdU. Arrows indicate BrdU 
+   cells. Bars: (top) 
50   μ  m; (bottom) 20   μ  m. (B and C) Quantiﬁ  cation of BrdU 
+   cells in the pe    -
ripheral retina (B; factorial ANOVA: F = 7.529; *, P = 0.0064) or in the 
CE (C; factorial ANOVA: F = 24.2; *, P = 0.0002). (D) Quantiﬁ  cation of 
BrdU 
+  /nestin 
+   (factorial ANOVA: F = 11.2; *, P = 0.003), BrdU 
+  /Pax6 
+   
(factorial ANOVA: F = 6.32; *, P = 0.019), and BrdU 
+  /Chx10 
+   (factorial 
ANOVA: F = 43.8; *, P = 0.0001) cells. Factorial ANOVA followed by 
Fisher  ’  s exact test; *, P = 0.05;   n   = 4  –  8. Error bars represent SEM.     JCB • VOLUME 183 • NUMBER 3 • 2008  398
in retinogenesis and RPC fate regulation. Revealing the specifi  c 
function of these family members necessitates further investiga-
tion. The unique features of the TLR family, including pattern 
recognition rather than identifi  cation of a single ligand and their 
ability to recognize stress-related compounds ( Johnson et al., 2003 ) 
progenitor cell proliferation are also evident in the adult hippocam-
pus (  Rolls et al., 2007  ), our results further emphasize the impor-
tance of this receptor family in neurogenic processes in general. 
 TLR4 is a member of a larger receptor family. Thus, our re-
sults suggest that additional members of this family may   participate 
  Figure 5.       TLR4 regulates the responsiveness of cells reminiscent of RPCs after administration of GFs.   (A) Semiquantitative PCR of PN6 and PN14 whole 
eyes for TLR4. (B and C) Pictures (B) and quantiﬁ  cation (C; factorial ANOVA: F = 4.069; *, P = 0.0434) of TLR4 immunoreactivity at various time points. 
(D and E) Quantiﬁ  cation of BrdU 
+   cells in the peripheral retina (D) and in CE (E; factorial ANOVA: F = 323; *, P = 0.0001 in D and F = 128; *, P = 0.0001 
in E). (F) Experimental design. TLR4D and WT PN15 mice received intravitreal injections of FGF-2 and insulin. (G) Staining for BrdU after GF treatment. 
  Arrows indicate BrdU 
+   cells. (H and I) Quantiﬁ  cation of BrdU 
+   cells in the CE (H) and in the peripheral retina (I; Student  ’  s   t   test; *, P   <   0.05; **, P   <   0.01) 
after GF treatment. (J) Quantiﬁ  cation of Ki67 
+   cells in the CE of untreated and GF-treated mice (factorial ANOVA: F = 7.529; *, P = 0.0064). (K) Quan-
tiﬁ  cation of BrdU 
+  /Pax6 
+   and BrdU 
+  /Chx10 
+   cells after GF treatment (Student  ’  s   t   test; *, P   <   0.05; ***, P   <   0.001). (L) Pictures of TLR4D retinas after GF 
treatment labeled for BrdU, Pax6, and Chx10. Arrows indicate double-positive cells. (M) Fold increase in BrdU 
+   cells in TLR4D retinas relative to control. 
Factorial ANOVA followed by Fisher  ’  s exact test; *, P = 0.05;   n   = 4  –  6. Asterisks denote signiﬁ  cant differences. Error bars represent SEM. Bars, 25   μ  m.     399 TOLL-LIKE RECEPTOR 4 IN RETINAL NEUROGENESIS   • Shechter et al. 
  RNA puriﬁ  cation, cDNA synthesis, and reverse-transcription PCR analysis 
  The primers used are listed in   Table II  . RNA procedures were performed 
as described previously (  Butovsky et al., 2006  ); RNA was prepared by 
homogenation of the eyes using a homogenator in TRI reagent (PRO250; 
Sigma-Aldrich) on ice or by treating RPCs with TRI reagent on ice. 
  Preparation of RPCs 
  RPCs were isolated and grown as previously described (  Neeley et al., 
2008  ). In brief, PN0 eyes were removed and placed in HBSS. Neural reti-
nas were carefully dissected away from the optic disc and ciliary marginal 
zone. Tissue was minced and digested in collagenase (0.1% in PBS, pH 
7.2  –  7.4; Sigma-Aldrich) at room temperature. Liberated cells were collected 
through a 100-  μ  m mesh strainer, centrifuged, and then resuspended in a 
neurobasal medium (Invitrogen) supplemented with 20 ng/ml EGF, 2% B-27 
supplement (Invitrogen), 1% N-2 neural supplement (Invitrogen), 100 mg/ml 
penicillin/streptomycin (Biological Industries), 2 mM   L  -glutamine (Biological 
Industries), and 20 U/ml nystatin (Invitrogen). Cells were transferred to a 
6-well plate and cultured at 37  °  C in a 5% CO  2   incubator. 0.5 ml of fresh 
medium was added to each well every 2 d. Primary neurospheres formed 
within the ﬁ  rst week in culture. These proliferating cultures were passaged 
weekly for 12 wk, at which point they were used for the experiments de-
scribed here. siRNA transfection of RPCs as well as proliferation, differentia-
tion, and survival assays were performed as described previously (  Rolls 
et al., 2007  ). upLPS (Invitrogen) was added to the desired ﬁ  nal concentra-
tion. For survival assays, 10   μ  g/ml aphidicolin (Sigma-Aldrich) was added 
to inhibit proliferation. Quantiﬁ  cation of cell proliferation/viability was deter-
mined by XTT (TOX2; Sigma-Aldrich), a spectrophotometric measurement of 
cell viability based on mitochondrial dehydrogenase activity. Sphere dia-
meter was calculated using Image-Pro software (Media Cybernetics, Inc.). 
  Image acquisition and quantiﬁ  cation 
  Cyanine dye (Cy2 [A492nm and E510nm], Cy3 [A550nm and E570nm], 
or Cy5 [A650nm and E670nm])  –  conjugated antibodies (Jackson Immuno-
Research Laboratories) were used to visualize antibody-bound molecules. 
For nuclear staining, we used Hoechst 33342 ﬂ  uorochrome (Invitrogen). 
The stained sections were mounted with glycerol vinyl alcohol mounting so-
lution (Invitrogen). For microscopic analysis, a ﬂ  uorescence  microscope 
(E800; Nikon) or laser-scanning confocal microscope (Carl Zeiss, Inc.) was 
used. The ﬂ  uorescence microscope was equipped with a digital camera 
(DXM 1200F; Nikon) and with either a 20  ×   NA 0.50 or 40  ×   NA 0.75 
objective lens (Plan Fluor; Nikon). The confocal microscope was equipped 
with LSM 510 laser scanning (three lasers: Ar 488, HeNe 543, and HeNe 
633) and with a 40  ×   oil-immersion NA 1.3 Plan Neoﬂ  uor objective lens. 
Recordings were made on postﬁ  xed tissues at 24  °  C using acquisition soft-
ware (ACT-1 [Nikon]; or LSM [Carl Zeiss, Inc.]). Images were cropped and 
optimized in Photoshop 9.0 (Adobe Systems, Inc.) by making minor ad-
justments to contrast and arranged using Canvas X (Deneba Software). 
or pathogens, provide RPCs with the capacity to respond to var-
ious deviations from homeostasis, such as injury. Our fi  nding 
that TLR4 restricts RPC proliferation might provide, at least in 
part, an explanation for the limited neurogenesis in response to 
injury (  Nickerson et al., 2007  ), a condition that releases a vari-
ety of ligands that can ultimately be recognized by the TLR 
family (  Vabulas et al., 2002  ). Revealing the mechanisms that 
constrain RPC proliferation has promising therapeutic poten-
tial for inducing neurogenesis in the adult eye under patho-
logical conditions. 
  Materials and methods 
  Animals 
  TLR4D mice (C57BL/10ScNJ; The Jackson Laboratory) and their WT 
C57BL/10 counterparts (a gift of I. Cohen, Weizmann Institute of Sci-
ence, Rehovot, Israel), MyD88-deﬁ   cient mice (a gift of S. Akira and 
S. Uematsu, Research Institute for Microbial Diseases, Osaka University, 
Osaka, Japan), TICAM1-deﬁ  cient mice (C57BL/6J-  AW046014 
Lps2    /J; The 
Jackson Laboratory), and WT C57BL/6 mice (supplied by the Animal 
Breeding Center of the Weizmann Institute of Science) were maintained 
at the Weizmann Institute Animal Facility. All animals were handled 
  according to the regulations formulated by the Institutional Animal Care 
and Use Committee. 
  Administration of BrdU 
  Animals were given intraperitoneal injections of 0.125 mg/gram of body 
weight of BrdU (Sigma-Aldrich). For proliferation assays, mice were killed 
6 h after injection, and their eyes were removed and prepared for histol-
ogy as described in the Immunohistochemistry section. For differentiation 
assays, injected mice were maintained for 7 d and then killed. 
  GF administration 
  TLR4D and C57BL/10 PN15 mice were anesthetized, and GFs (20 ng/  μ  l 
FGF-2 and 1   μ  g/  μ  l insulin) together with 1   μ  g/  μ  l BrdU were delivered into 
left eyes by intravitreal injection using a glass micropipette attached to a 
10-  μ  l Hamilton syringe (total volume of 1   μ  l/eye). Mice were injected on 
four consecutive days and killed 24 h after the last injection. Eyes were re-
moved and prepared for histology as described in the next section. 
  Immunohistochemistry 
  Mice eyes were placed in 2.5% paraformaldehyde for 48 h and moved 
to 70% ethyl alcohol. The tissues were prepared for histology and stained 
as previously described (  Shechter et al., 2007  ). The antibodies used are 
listed in   Table I  . 
  Table II.       Primers used in this paper   
Primer pairs  Sense and antisense sequences
    -Actin 5    -TAAAACGCAGCTCAGTAACAGTCCG-3      
  5    -TGGAATCCTGTGGCATCCATGAAAC-3   
TLR1 5    -ATGATTCTGCCTGGGTGAAG-3      
  5    -TCTGGATGAAGTGGGGAGAC-3   
TLR2 5    -CTCCCACTTCAGGCTCTTTG-3      
  5    -AGGAACTGGGTGGAGAACCT-3   
TLR3 5    -AGCTTTGCTGGGAACTTTCA-3      
  5    -GAAAGATCGAGCTGGGTGAG-3   
TLR4 5    -CAGCAAAGTCCCTGATGACA-3      
  5    -AGAGGTGGTGTAAGCCATGC-3   
TLR5 5    -ATTCTCATCGTGGTGGTGGT-3      
  5    -GCTATGGTTCGCAACTGGAT-3   
TLR6 5    -ACACAATCGGTTGCAAAACA-3      
  5    -GGAAAGTCAGCTTCGTCAGG-3   
TLR7 5    -CCACAGGCTCACCCATACTT-3      
  5    -CAAGGCATGTCCTAGGTG-3   
TLR8 5    -GGCACAACTCCCTTGTGATT-3      
  5    -CATTTGGGTGCTGTTGTTTG-3   
TLR9 5    -GCTTTGGCCTTTCACTCTTG-3      
  5    -AACTGCGCTCTGTGCCTTAT-3   
  Table I.       First antibodies used in this paper   
Source Dilution Species Antigen
Abcam 1:50 Rabbit TLR4
Cedarlane 1:100 Rat CD34
Abcam 1:100 Mouse CK18
Invitrogen 1:75 Mouse CK AE1/AE3
Cell Signaling
Technology
1:50 Rabbit Cleaved  
       caspase 3
Abcam 1:200 Sheep Chx10
AbD Serotec 1:100 Rat BrdU
Millipore 1:100 Mouse Nestin
Santa Cruz
Biotechnology, Inc.
1:100 Goat DCX
Millipore 1:500 Rabbit Pax6
Covance 1:500 Rabbit     IIIT
Dako 1:50 Rat Ki67
Santa Cruz
Biotechnology, Inc.
1:200 Rabbit PKC-   
Millipore 1:1,000 Rabbit RecoverinJCB • VOLUME 183 • NUMBER 3 • 2008  400
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The number of cells in the peripheral retina and immunoreactivity in the 
CE was determined automatically with Image-Pro Plus 4.5 software 
(Media Cybernetics, Inc.). All measurements were performed by an 
observer blinded as to the identity of the examined tissues. 
  Statistical analysis 
  The results were analyzed by Student  ’  s   t   test or factorial analysis of   
variance (ANOVA) followed by Fisher  ’  s exact test and are expressed as 
means   ±   SEM. 
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